---
layout: post
title: "Aliskiren: Direct Renin Inhibitor Baru pada Terapi Hipertensi"
author: "Ni Putu Uma Sari Dewi, I Gusti Ayu Artini Ekajaya Amandari, Made Winda Krisnayanti, Made Ary Sarasmita"
description: "Hipertensi merupakan kondisi ketika tekanan darah meningkat secara kronis Mengacu pada hasil Riset Kesehatan Dasar Riskesdas Bali memiliki proporsi hipertensi sebesa"
categories: jfu
canonical_url: https://jurnal.harianregional.com/jfu/id-39874
comments: true
citation_abstract_html_url: "https://jurnal.harianregional.com/jfu/id-39874"
citation_pdf_url: "https://jurnal.harianregional.com/jfu/full-39874"
tags:

---

## Authors:
Ni Putu Uma Sari Dewi, I Gusti Ayu Artini Ekajaya Amandari, Made Winda Krisnayanti, Made Ary Sarasmita

## Abstract:
"Hipertensi merupakan kondisi ketika tekanan darah meningkat secara kronis. Mengacu pada hasil Riset Kesehatan Dasar (Riskesdas), Bali memiliki proporsi hipertensi sebesar 19,9%. Beberapa studi epidemiologis menyebutkan bahwa risiko kerusakan berbagai organ vital secara langsung berkorelasi dengan peningkatan tekanan darah. Oleh karena itu, diperlukan keteraturan dalam mengontrol dan juga meminum obat antihipertensi. Obat antihipertensi yang umum digunakan saat ini adalah angiotensin converting enzyme inhibitor (ACEI) dan angiotensin receptor blocker (ARB). Akan tetapi, temuan sebelumnya menyatakan bahwa ACEI dan ARB belum sepenuhnya efektif dalam menurunkan tekanan darah. Untuk mengatasi kelemahan tersebut, ditemukan direct renin inhibitor baru yaitu aliskiren. Aliskiren dapat memblokade renin-angiotensin-aldosterone system (RAAS) pada level tertinggi, sehingga kemampuan aliskiren dalam menurunkan tekanan darah tidak dapat diragukan lagi. Aliskiren mampu menghambat konversi angiotensinogen menjadi angiotensin I, sehingga dapat menurunkan tekanan darah secara berkelanjutan."

### Keywords
*Keyword Not Available*

### Downloads:
Download data is not yet available.

{% include adsense.html %}
## References
- Brown, M. J. 2008. Aliskiren. Circulation. 118: 773-784.
- Burchum, J. and L. Rosenthal. 2016. Lehne’s Pharmacotherapeutics for Nurse Practitioners and Physician Assistants. St. Louis: Elsevier.
- Cromer, J. and S. Peker. 2008. Aliskiren (Tekturna), A Novel Antihypertensive Approach to Inhibition of the Renin-Angiotensin-Aldosterone System. Drug Forecast. 33(2): 92-96.
- Dieterich, H., et al. 2006. Aliskiren, the First in a New Class of Orally Effective Renin Inhibitors, Has No Clinically Significant Drug Interactions with Digoxin in Healthy Volunteers. Clin. Pharmacol. Ther. 79: 64.
- Dieterle, W. et al. 2004. Effect of the Oral Renin Inhibitor Aliskiren on the Pharmacokinetics and Pharmacodynamics of a Single Dose of Warfarin in Healthy Subjects. Br. J. Clin. Pharmacol. 58: 433-436.
- Drummond, W., et al. Antihypertensive Efficacy of the Oral Direct Renin Inhibitor Aliskiren as Add-on Therapy in Patients Not Responding to Amlodipine Monotherapy. J. Clin. Hypertens. 9: 742-750.
- Izzo, J. L. et al. 2008. Hypertension Primer. 4th Edition. USA: Lippincott Williams and Wilkins.
- Kemenkes RI. 2014. Infodatin: Hipertensi. Jakarta: Kementerian Kesehatan Republik Indonesia.
- Nadeem, S. and D. L. Batisky. 2014. Aliskiren, the First Direct Renin Inhibitor: Assessing a Role in Pediatric Hypertension and Kidney Diseases. Pediatric Nephrology. 29(11): 2105-2111.
- Riskesdas. 2013. Riset Kesehatan Dasar. Jakarta: Kementerian Kesehatan Republik Indonesia.
- Schmieder, R. E., et al. 2007. Aliskiren-based Therapy Lowers Blood Pressure More Effectively than Hydrochlorothiazide-based Therapy in Patients with Hypertension. J. Clin. Hypertens. 9: 182.
- Sica, D. A. 2009. Textbook of Nephro-Endocrinology. St. Louis: Elsevier.
- Strasser, R. H., et al. 2007. A Comparison of the Tolerability of the Direct Renin Inhibitor Aliskiren and Lisinopril in Patients with Severe Hypertension. J. Hum. Hypertens. 21: 780-787.
- Vaidyanathan, S., et al. Aliskiren, a Novel Orally Effective Renin Inhibitor, Exhibits Similar Pharmacokinetics and Pharmacodynamics in Japanese and Caucasian Subjects. Br. J. Clin. Pharmacol. 62(6): 690-698.
- Villamil, A., et al. 2007. Renin Inhibition with Aliskiren Provides Additive Antihypertensive Efficacy when Used in Combination with Hydrochlorothiazide. J. Hypertens. 25(1): 217-226.
- Wal, P., et al. 2011. Aliskiren: An Orally Active Renin Inhibitor. Journal of Pharmacy and Bioallied Sciences. 3(2): 189-193.

### PDF:

{% include adsense1.html %}

<https://jurnal.harianregional.com/jfu/full-39874>

{% include adsense2.html %}

### Published
2020-01-21

### How To Cite
DEWI, Ni Putu Uma Sari et al.  Aliskiren: Direct Renin Inhibitor Baru pada Terapi Hipertensi.Jurnal Farmasi Udayana, [S.l.], p. 59, jan. 2020. ISSN 2622-4607. Available at: <https://jurnal.harianregional.com/jfu/id-39874>. Date accessed: {{ site.time | date: "%d %b. %Y" }}. doi:https://doi.org/10.24843/JFU.2019.v08.i02.p01.

## Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

### Issue
Vol. 8, No. 2, Tahun 2019

### Section 
**Articles**

### Copyright 
{% include inarticle.html %}
<a href="http://creativecommons.org/licenses/by/4.0/" rel="license"><img src="https://i.creativecommons.org/l/by/4.0/88x31.png" alt="Creative Commons License" /></a>
This work is licensed under a <a href="http://creativecommons.org/licenses/by/4.0/" rel="nofollow">Creative Commons Attribution 4.0 International License</a>

{% include multiplex.html %}
